CN Stock MarketDetailed Quotes

688117 ChengDu Sheng Nuo Biotec

Watchlist
  • 31.14
  • -0.92-2.87%
Market Closed Nov 13 15:00 CST
3.49BMarket Cap37.70P/E (TTM)

ChengDu Sheng Nuo Biotec Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
16.00%337.84M
14.44%198.94M
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
Operating revenue
16.00%337.84M
14.44%198.94M
27.65%104.06M
9.93%435.02M
11.82%291.23M
3.78%173.83M
0.96%81.52M
2.38%395.72M
-6.70%260.43M
-13.49%167.51M
Total operating cost
6.79%272.01M
11.99%176.47M
19.14%86.93M
11.01%357.48M
17.38%254.71M
5.89%157.57M
10.64%72.96M
1.61%322.02M
-5.88%216.99M
-10.23%148.81M
Operating cost
28.56%138.54M
31.65%80.4M
32.20%38.37M
15.37%157.65M
14.95%107.76M
2.29%61.07M
10.01%29.03M
26.13%136.64M
33.17%93.75M
26.27%59.71M
Operating tax surcharges
21.51%3.17M
41.14%2.58M
122.81%1.32M
-14.54%4.03M
-22.69%2.61M
-26.67%1.83M
-53.10%594.35K
-1.71%4.72M
1.68%3.37M
7.56%2.49M
Operating expense
-38.05%49.35M
-26.85%35.68M
19.93%23.18M
-4.65%107.97M
6.91%79.66M
-4.27%48.77M
-20.92%19.33M
-25.37%113.24M
-39.40%74.52M
-43.38%50.95M
Administration expense
11.04%45.28M
-0.75%30.48M
-25.85%12.62M
17.92%53.86M
39.73%40.78M
45.14%30.71M
86.15%17.02M
13.75%45.68M
7.65%29.19M
10.10%21.16M
Financial expense
101.61%7.09M
74.16%3.49M
-5.30%2.02M
417.50%4.91M
232.06%3.52M
232.99%2.01M
639.17%2.14M
16.31%-1.55M
-23.85%-2.66M
-434.76%-1.51M
-Interest expense (Financial expense)
31.10%8.96M
21.24%5.27M
47.75%2.94M
164.68%9.26M
199.24%6.83M
303.35%4.34M
339.82%1.99M
1,949.84%3.5M
8,811.52%2.28M
--1.08M
-Interest Income (Financial expense)
37.43%-1.71M
38.82%-1.23M
-14.86%-838.48K
-86.50%-3.92M
-96.23%-2.73M
-78.71%-2.01M
-20.48%-729.97K
23.19%-2.1M
46.39%-1.39M
-70.84%-1.13M
Research and development
40.22%28.58M
80.85%23.83M
93.65%9.42M
24.74%29.05M
8.23%20.38M
-17.69%13.18M
-4.87%4.86M
69.40%23.29M
111.11%18.83M
120.57%16.01M
Credit Impairment Loss
-58.99%-943.03K
397.80%1.95M
408.03%1.43M
12.71%-3.05M
-3.57%-593.15K
-200.53%-656.3K
-208.26%-464.7K
-171.12%-3.49M
-275.10%-572.68K
13.44%-218.38K
Asset Impairment Loss
-10.70%-4.72M
-88.99%-4.75M
-289.31%-874.48K
-2.68%-4.93M
-361.49%-4.26M
-4,699.08%-2.51M
-3,393.77%-224.62K
-280.75%-4.8M
-221.60%-924.17K
90.59%-52.39K
Other net revenue
Invest income
169.31%624.14K
272.73%697.98K
153.81%298.89K
-157.63%-1.42M
-163.84%-900.47K
-146.82%-404.08K
-150.70%-555.46K
68.33%2.47M
--1.41M
--863.08K
-Including: Investment income associates
----
----
----
-66.18%-3.17M
----
----
----
---1.91M
----
----
Asset deal income
-250.15%-3.72K
103.30%35
103.30%35
98.66%-1.06K
90.48%-1.06K
90.48%-1.06K
90.48%-1.06K
-487.73%-79.37K
---11.15K
---11.15K
Other revenue
-67.77%3.6M
-68.01%3.44M
-82.22%1.61M
156.62%12.96M
255.64%11.18M
334.04%10.74M
579.05%9.04M
-30.84%5.05M
-31.97%3.14M
-32.59%2.47M
Operating profit
53.53%64.38M
1.61%23.81M
19.82%19.59M
11.34%81.1M
-9.79%41.94M
7.69%23.43M
-7.31%16.35M
-3.92%72.84M
-12.68%46.49M
-29.20%21.76M
Add:Non operating Income
-34.82%207.58K
-89.47%26.11K
265,909.48%21.33K
9,770.38%333.48K
3,473.84%318.49K
2,926.72%247.89K
-99.90%8.02
-83.59%3.38K
-92.56%8.91K
-93.14%8.19K
Less:Non operating expense
-43.79%668.77K
-40.29%533.42K
1,780.04%307.63K
173.22%1.31M
207.97%1.19M
151.89%893.34K
-80.75%16.36K
-91.01%480.58K
-86.35%386.33K
-85.13%354.66K
Total profit
55.66%63.92M
2.26%23.3M
18.19%19.3M
10.72%80.12M
-10.94%41.06M
6.42%22.78M
-7.00%16.33M
2.66%72.36M
-8.74%46.11M
-24.78%21.41M
Less:Income tax cost
13.36%7.1M
-40.00%1.58M
24.08%2.85M
24.34%9.8M
-11.77%6.27M
-4.79%2.64M
-29.65%2.3M
-14.68%7.88M
-5.18%7.1M
-37.84%2.77M
Net profit
63.28%56.82M
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
Net profit from continuing operation
63.28%56.82M
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
Less:Minority Profit
---130.62K
---69.31K
---22.09K
---12.7K
----
----
----
----
----
----
Net profit of parent company owners
63.66%56.95M
8.14%21.79M
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
Earning per share
Basic earning per share
64.52%0.51
5.56%0.19
15.38%0.15
8.62%0.63
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
Diluted earning per share
64.52%0.51
5.56%0.19
15.38%0.15
6.90%0.62
-11.43%0.31
5.88%0.18
-27.78%0.13
-31.76%0.58
-43.55%0.35
-55.26%0.17
Other composite income
Total composite income
63.28%56.82M
7.79%21.72M
17.23%16.45M
9.06%70.32M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
Total composite income of parent company owners
63.66%56.95M
8.14%21.79M
17.38%16.47M
9.08%70.34M
-10.79%34.8M
8.09%20.15M
-1.82%14.03M
5.28%64.48M
-9.36%39.01M
-22.36%18.64M
Total composite income of minority owners
---130.62K
---69.31K
---22.09K
---12.7K
----
----
----
----
----
----
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
--
Tianjian Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue 16.00%337.84M14.44%198.94M27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M
Operating revenue 16.00%337.84M14.44%198.94M27.65%104.06M9.93%435.02M11.82%291.23M3.78%173.83M0.96%81.52M2.38%395.72M-6.70%260.43M-13.49%167.51M
Total operating cost 6.79%272.01M11.99%176.47M19.14%86.93M11.01%357.48M17.38%254.71M5.89%157.57M10.64%72.96M1.61%322.02M-5.88%216.99M-10.23%148.81M
Operating cost 28.56%138.54M31.65%80.4M32.20%38.37M15.37%157.65M14.95%107.76M2.29%61.07M10.01%29.03M26.13%136.64M33.17%93.75M26.27%59.71M
Operating tax surcharges 21.51%3.17M41.14%2.58M122.81%1.32M-14.54%4.03M-22.69%2.61M-26.67%1.83M-53.10%594.35K-1.71%4.72M1.68%3.37M7.56%2.49M
Operating expense -38.05%49.35M-26.85%35.68M19.93%23.18M-4.65%107.97M6.91%79.66M-4.27%48.77M-20.92%19.33M-25.37%113.24M-39.40%74.52M-43.38%50.95M
Administration expense 11.04%45.28M-0.75%30.48M-25.85%12.62M17.92%53.86M39.73%40.78M45.14%30.71M86.15%17.02M13.75%45.68M7.65%29.19M10.10%21.16M
Financial expense 101.61%7.09M74.16%3.49M-5.30%2.02M417.50%4.91M232.06%3.52M232.99%2.01M639.17%2.14M16.31%-1.55M-23.85%-2.66M-434.76%-1.51M
-Interest expense (Financial expense) 31.10%8.96M21.24%5.27M47.75%2.94M164.68%9.26M199.24%6.83M303.35%4.34M339.82%1.99M1,949.84%3.5M8,811.52%2.28M--1.08M
-Interest Income (Financial expense) 37.43%-1.71M38.82%-1.23M-14.86%-838.48K-86.50%-3.92M-96.23%-2.73M-78.71%-2.01M-20.48%-729.97K23.19%-2.1M46.39%-1.39M-70.84%-1.13M
Research and development 40.22%28.58M80.85%23.83M93.65%9.42M24.74%29.05M8.23%20.38M-17.69%13.18M-4.87%4.86M69.40%23.29M111.11%18.83M120.57%16.01M
Credit Impairment Loss -58.99%-943.03K397.80%1.95M408.03%1.43M12.71%-3.05M-3.57%-593.15K-200.53%-656.3K-208.26%-464.7K-171.12%-3.49M-275.10%-572.68K13.44%-218.38K
Asset Impairment Loss -10.70%-4.72M-88.99%-4.75M-289.31%-874.48K-2.68%-4.93M-361.49%-4.26M-4,699.08%-2.51M-3,393.77%-224.62K-280.75%-4.8M-221.60%-924.17K90.59%-52.39K
Other net revenue
Invest income 169.31%624.14K272.73%697.98K153.81%298.89K-157.63%-1.42M-163.84%-900.47K-146.82%-404.08K-150.70%-555.46K68.33%2.47M--1.41M--863.08K
-Including: Investment income associates -------------66.18%-3.17M---------------1.91M--------
Asset deal income -250.15%-3.72K103.30%35103.30%3598.66%-1.06K90.48%-1.06K90.48%-1.06K90.48%-1.06K-487.73%-79.37K---11.15K---11.15K
Other revenue -67.77%3.6M-68.01%3.44M-82.22%1.61M156.62%12.96M255.64%11.18M334.04%10.74M579.05%9.04M-30.84%5.05M-31.97%3.14M-32.59%2.47M
Operating profit 53.53%64.38M1.61%23.81M19.82%19.59M11.34%81.1M-9.79%41.94M7.69%23.43M-7.31%16.35M-3.92%72.84M-12.68%46.49M-29.20%21.76M
Add:Non operating Income -34.82%207.58K-89.47%26.11K265,909.48%21.33K9,770.38%333.48K3,473.84%318.49K2,926.72%247.89K-99.90%8.02-83.59%3.38K-92.56%8.91K-93.14%8.19K
Less:Non operating expense -43.79%668.77K-40.29%533.42K1,780.04%307.63K173.22%1.31M207.97%1.19M151.89%893.34K-80.75%16.36K-91.01%480.58K-86.35%386.33K-85.13%354.66K
Total profit 55.66%63.92M2.26%23.3M18.19%19.3M10.72%80.12M-10.94%41.06M6.42%22.78M-7.00%16.33M2.66%72.36M-8.74%46.11M-24.78%21.41M
Less:Income tax cost 13.36%7.1M-40.00%1.58M24.08%2.85M24.34%9.8M-11.77%6.27M-4.79%2.64M-29.65%2.3M-14.68%7.88M-5.18%7.1M-37.84%2.77M
Net profit 63.28%56.82M7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M
Net profit from continuing operation 63.28%56.82M7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M
Less:Minority Profit ---130.62K---69.31K---22.09K---12.7K------------------------
Net profit of parent company owners 63.66%56.95M8.14%21.79M17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M
Earning per share
Basic earning per share 64.52%0.515.56%0.1915.38%0.158.62%0.63-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17
Diluted earning per share 64.52%0.515.56%0.1915.38%0.156.90%0.62-11.43%0.315.88%0.18-27.78%0.13-31.76%0.58-43.55%0.35-55.26%0.17
Other composite income
Total composite income 63.28%56.82M7.79%21.72M17.23%16.45M9.06%70.32M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M
Total composite income of parent company owners 63.66%56.95M8.14%21.79M17.38%16.47M9.08%70.34M-10.79%34.8M8.09%20.15M-1.82%14.03M5.28%64.48M-9.36%39.01M-22.36%18.64M
Total composite income of minority owners ---130.62K---69.31K---22.09K---12.7K------------------------
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Tianjian Certified Public Accountants (Special General Partnership)------Tianjian Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data